PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Nano-Regenerative Medicine, Faculty of Medicine, Universidad de los Andes, Santiago, Chile.\', \'Cells for Cells and Consorcio Regenero, Chilean Consortium for Regenerative Medicine, Santiago, Chile.\', \'Department of Oral Biology, The State University of New York, Buffalo, New York, USA.\', \'Division of Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Modena, Italy.\', \'Department of Laboratory Medicine, Karolinska Institutet, CAST, Patient Area Cell Therapies and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.\', \'Center for Cellular Immunotherapies, Department of Pathology and Laboratory Medicine, and Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.\', \'Department of Medicine, University of Vermont, Burlington, Vermont, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1089/scd.2020.0122
?:doi
?:hasPublicationType
?:journal
  • Stem cells and development
is ?:pmid of
?:pmid
?:pmid
  • 33307968
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.426
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • The Coronavirus Pandemic: A Pitfall or a Fast Track for Validating Cell Therapy Products?
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33307968>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33307968>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all